News
Phase 1 clinical trial of HIV vaccine starts in Africa to evaluate immune responses to highly networked HIV T-cell epitopes
9+ mon, 1+ week ago (172+ words) Led by a team of African researchers, first doses of the novel T cell-inducing GRAd HIVNE1 vaccine candidate have been given....
IAVI celebrates new results supporting its HIV vaccine development strategy this HIV Vaccine Awareness Day
11+ mon, 4+ week ago (16+ words) IAVI commemorates HVAD, plus new publications in Science demonstrate proof-of-concept for sequential immunization strategy....
HIV Vaccine Awareness Day 2026: African research leading the charge
4+ hour, 30+ min ago (287+ words) Home / Features / HIV Vaccine Awareness Day 2026: African researchleading the charge Funding for this clinical trial has been provided by the Gates Foundationthrough the'Collaboration for AIDS Vaccine Discovery (CAVD), with funding for the clinical trial materials provided through the Scripps Research…...
IAVI begins first-in-human Phase 1 trial of single-dose Marburg virus vaccine candidate
1+ mon, 1+ week ago (440+ words) Home / Press Releases / IAVI begins first-in-human Phase 1 trial of single-dose Marburg virus vaccine candidate NEW YORK, NY'April 6, 2026'IAVI, a global nonprofit biomedical research organization, announced today that the first participants have been vaccinated with a Marburg virus (MARV) vaccine candidate…...
IAVI announces the onset of first-in-human Phase 1 clinical trial of broadly neutralizing antibodies (bn Abs) to prevent HIV transmission
1+ mon, 2+ week ago (109+ words) Home / Features / IAVI announces the onset of first-in-human Phase 1 clinical trial of broadly neutralizing antibodies (bn Abs) to prevent HIV transmission The state of vaccine science now is far more powerful and sophisticated than it has ever been. And I…...
Communities are front and center in'tuberculosis (TB)'vaccine advocacy this'World TB Day'
1+ mon, 3+ week ago (312+ words) Home / Features / Communities are front and center in'tuberculosis (TB)'vaccine advocacy this'World TB Day' With promising TB vaccines currently in late-stage development, the TB vaccine field faces an unmissable opportunity to develop and deliver vaccines'with communities firmly'at the core.'The…...
Ending neglected diseases requires partners willing to go where markets won't
3+ mon, 2+ week ago (246+ words) Home / Features / Ending neglected diseases requires partners willing to go where markets won't For three decades, IAVI has worked to develop vaccines and antibodies for diseases that lack the commercial incentives to attract private investment, yet these diseases still cause…...
IAVI announces first vaccinations in IAVI G004, a Phase 1 clinical trial of a promising HIV vaccine approach
4+ mon, 1+ week ago (611+ words) IAVI Home / Press Releases / IAVI announces first vaccinations in IAVI G004, a Phase 1 clinical trial of a promising HIV vaccine approach Study will examine safety, immune response, and dose of three promising immunogens - In 2024, 40. 8 million people were living with HIV, and…...